Mechanistically, CD28-costimulated RCC CD8+ TILs also showed increased anabolic glycolysis and mitochondrial metabolism, both of which were critically maintained by glucose metabolism, as the glycolytic inhibitor 2-deoxyglucose suppressed TIL mitochondrial fusion and accumulation, as well as activation and proliferation. Here, CD28 is linked to renal cell carcinoma.